A migraine is usually a moderate or severe headache felt as a throbbing pain on 1 side of the head. Many people also have symptoms such as feeling sick, being sick and increased sensitivity to light or sound. Migraine is a common health condition, affecting around 1 in every 5 women and around 1 in every 15 men. They usually begin in early adulthood.


We have developed a suite of patient resources designed to support your patients on their treatment with Aimovig®. These support tools include:


1. www.aimoassist.ie (password for entry required: “aimovig” - all lower case)

This is a patient focused website providing useful information for patients starting treatment with Aimovig®, including an injection training video, instructions for use, support tools, and hints and tips for managing treatment with Aimovig®.

2. Aimovig® Nurse Support Programme

This is a free programme designed to provide education and support to patients throughout their Aimovig® treatment experience should they require it. Once patients register for the programme, the Aimovig® Support Nurse will contact them and will be on hand to provide personalised support for their Aimovig® treatment. Home visits with the Aimovig® Novartis Nurse can be arranged should your patients require it.

3. Aimovig® Sharps Container Service

The Aimovig® Sharps Container Service provides a sharps container delivery and collection service to Aimovig® patients. The service is provided to patients free of charge by Point of Care Health Services on behalf of Novartis, the manufacturers of Aimovig®.

4. Migraine Buddy

Migraine Buddy* is a digital migraine diary app that your patients can download free of charge on a mobile phone or tablet. It offers an intuitive interface with an easy-to-use questionnaire to track and manage migraine attacks. It is available for download on the App Store and Google Play Store.

5. www.dontforget.ie

www.dontforget.ie is a free medication reminder service. Patients can sign up to have a text sent directly to their phone every 4 weeks to remind them to take their Aimovig® medication. Patients can register for this free service via www.dontforget.ie.

*Novartis is a preferred partner of Healint Pte, which independently developed, owns and operates Migraine Buddy.

Rate this content: 
No votes yet
IE270600 | March 2023

Ask Speakers


Medical Information Request

Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.